Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit

Cell Stem Cell

Volumn 14, Issue 6, 2014, Pages 824-837

  Medyouf, Hind ^a   Mossner, Maximilian ^b   Jann, Johann Christoph ^b   Nolte, Florian ^b   Raffel, Simon ^c   Herrmann, Carl ^a,d   Lier, Amelie ^c   Eisen, Christian ^c   Nowak, Verena ^b   Zens, Bettina ^a,c   Müdder, Katja ^a,c   Klein, Corinna ^a,c   Obländer, Julia ^b   Fey, Stephanie ^b   Vogler, Jovita ^b   Fabarius, Alice ^b   Riedl, Eva ^b   Roehl, Henning ^b   Kohlmann, Alexander ^e   Staller, Marita ^e   Haferlach, Claudia ^e   Müller, Nadine ^b   John, Thilo ^f   Platzbecker, Uwe ^g   Metzgeroth, Georgia ^b   Hofmann, Wolf Karsten ^b   Trumpp, Andreas ^a,c   Nowak, Daniel ^b   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Exp Hematology Group Heidelberg Institute for Stem Cell Technology and Experimental Medicine GGmbH   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e MLL MUNICH LEUKEMIA LABORATORY   (Germany)

^f DRK KLINIKEN BERLIN WESTEND   (Germany)

^g UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIBODY; LEUKEMIA INHIBITORY FACTOR; NERVE CELL ADHESION MOLECULE; SOMATOMEDIN B; VASCULOTROPIN A; CD38 ANTIGEN; LEUKOCYTE MIGRATION INHIBITION FACTOR; SOMATOMEDIN BINDING PROTEIN 2;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL EXPANSION; CELL INTERACTION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENETIC ANALYSIS; HEMATOPOIETIC CELL; HUMAN; IN VIVO STUDY; MESENCHYMAL STROMA CELL; MOUSE; MYELODYSPLASTIC SYNDROME; NONHUMAN; NUCLEAR REPROGRAMMING; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; STEM CELL NICHE; STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL MODEL; CD34 SELECTION; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; PROTEIN TARGETING; STEM CELL EXPANSION; STROMA CELL; XENOGRAFT; AGED; ANIMAL; KNOCKOUT MOUSE; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; SCID MOUSE;

AGED; ANIMALS; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; MYELODYSPLASTIC SYNDROMES; STEM CELL NICHE;

EID: 84902200836     PISSN: 19345909     EISSN: 18759777     Source Type: Journal    
DOI: 10.1016/j.stem.2014.02.014     Document Type: Article

References (44)

1. O. Abdel-Wahab, J. Gao, M. Adli, A. Dey, T. Trimarchi, Y.R. Chung, C. Kuscu, T. Hricik, D. Ndiaye-Lobry, and L.M. Lafave et al. Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo J. Exp. Med. 210 2013 2641 2659
2. R. Bejar, K. Stevenson, O. Abdel-Wahab, N. Galili, B. Nilsson, G. Garcia-Manero, H. Kantarjian, A. Raza, R.L. Levine, D. Neuberg, and B.L. Ebert Clinical effect of point mutations in myelodysplastic syndromes N. Engl. J. Med. 364 2011 2496 2506
3. R. Bejar, K.E. Stevenson, B.A. Caughey, O. Abdel-Wahab, D.P. Steensma, N. Galili, A. Raza, H. Kantarjian, R.L. Levine, and D. Neuberg et al. Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes J. Clin. Oncol. 30 2012 3376 3382
4. P. Bianco, X. Cao, P.S. Frenette, J.J. Mao, P.G. Robey, P.J. Simmons, and C.Y. Wang The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine Nat. Med. 19 2013 35 42
5. O. Blau, W.K. Hofmann, C.D. Baldus, G. Thiel, V. Serbent, E. Schümann, E. Thiel, and I.W. Blau Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia Exp. Hematol. 35 2007 221 229
6. M.R. Corces-Zimmerman, W.J. Hong, I.L. Weissman, B.C. Medeiros, and R. Majeti Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission Proc. Natl. Acad. Sci. USA 111 2014 2548 2553
7. C.L. da Silva, R. Gonçalves, K.B. Crapnell, J.M. Cabral, E.D. Zanjani, and G. Almeida-Porada A human stromal-based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells Exp. Hematol. 33 2005 828 835
8. A.C. Drake, M. Khoury, I. Leskov, B.P. Iliopoulou, M. Fragoso, H. Lodish, and J. Chen Human CD34+ CD133+ hematopoietic stem cells cultured with growth factors including Angptl5 efficiently engraft adult NOD-SCID Il2rγ-/- (NSG) mice PLoS ONE 6 2011 e18382
9. B. Dykstra, S. Olthof, J. Schreuder, M. Ritsema, and G. de Haan Clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells J. Exp. Med. 208 2011 2691 2703
10. J.L. Escary, J. Perreau, D. Duménil, S. Ezine, and P. Brûlet Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation Nature 363 1993 361 364
11. E. Flores-Figueroa, R.M. Arana-Trejo, G. Gutiérrez- Espíndola, A. Pérez-Cabrera, and H. Mayani Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization Leuk. Res. 29 2005 215 224
12. G. Garcia-Manero Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management Am. J. Hematol. 87 2012 692 701
13. V. Grossmann, A. Roller, H.U. Klein, S. Weissmann, W. Kern, C. Haferlach, M. Dugas, T. Haferlach, S. Schnittger, and A. Kohlmann Robustness of amplicon deep sequencing underlines its utility in clinical applications J. Mol. Diagn. 15 2013 473 484
14. T. Haferlach, Y. Nagata, V. Grossmann, Y. Okuno, U. Bacher, G. Nagae, S. Schnittger, M. Sanada, A. Kon, and T. Alpermann et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes Leukemia 28 2014 241 247
15. H. Huynh, J. Zheng, M. Umikawa, C. Zhang, R. Silvany, S. Iizuka, M. Holzenberger, W. Zhang, and C.C. Zhang IGF binding protein 2 supports the survival and cycling of hematopoietic stem cells Blood 118 2011 3236 3243
16. M. Jan, T.M. Snyder, M.R. Corces-Zimmerman, P. Vyas, I.L. Weissman, S.R. Quake, and R. Majeti Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia Sci. Transl. Med. 4 2012 ra118
17. A. Kode, J.S. Manavalan, I. Mosialou, G. Bhagat, C.V. Rathinam, N. Luo, H. Khiabanian, A. Lee, V.V. Murty, and R. Friedman et al. Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts Nature 506 2014 240 244
18. A. Kohlmann, H.U. Klein, S. Weissmann, S. Bresolin, T. Chaplin, H. Cuppens, E. Haschke-Becher, B. Garicochea, V. Grossmann, and B. Hanczaruk et al. The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories Leukemia 25 2011 1840 1848
19. H.J. Lawrence, V.C. Broudy, R.E. Magenis, S. Olson, D. Tomar, S. Barton, J.H. Fitchen, and G.C. Bagby Jr. Cytogenetic evidence for involvement of B lymphocytes in acquired idiopathic sideroblastic anemias Blood 70 1987 1003 1005
20. M.G. Martin, J.S. Welch, G.L. Uy, T.A. Fehniger, S. Kulkarni, E.J. Duncavage, and M.J. Walter Limited engraftment of low-risk myelodysplastic syndrome cells in NOD/SCID gamma-C chain knockout mice Leukemia 24 2010 1662 1664
21. A. Matsuoka, A. Tochigi, M. Kishimoto, T. Nakahara, T. Kondo, T. Tsujioka, T. Tasaka, Y. Tohyama, and K. Tohyama Lenalidomide induces cell death in an MDS-derived cell line with deletion of chromosome 5q by inhibition of cytokinesis Leukemia 24 2010 748 755
22. P.H. Miller, A.M. Cheung, P.A. Beer, D.J. Knapp, K. Dhillon, G. Rabu, S. Rostamirad, R.K. Humphries, and C.J. Eaves Enhanced normal short-term human myelopoiesis in mice engineered to express human-specific myeloid growth factors Blood 121 2013 e1 e4
23. Y. Muguruma, H. Matsushita, T. Yahata, S. Yumino, Y. Tanaka, H. Miyachi, Y. Ogawa, H. Kawada, M. Ito, and K. Ando Establishment of a xenograft model of human myelodysplastic syndromes Haematologica 96 2011 543 551
24. T. Muto, G. Sashida, M. Oshima, G.R. Wendt, M. Mochizuki-Kashio, Y. Nagata, M. Sanada, S. Miyagi, A. Saraya, and A. Kamio et al. Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders J. Exp. Med. 210 2013 2627 2639
25. L. Nilsson, I. Astrand-Grundström, I. Arvidsson, B. Jacobsson, E. Hellström-Lindberg, R. Hast, and S.E. Jacobsen Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level Blood 96 2000 2012 2021
26. D. Nowak, M. Klaumuenzer, B. Hanfstein, M. Mossner, F. Nolte, V. Nowak, J. Oblaender, A. Hecht, G. Hütter, and S. Ogawa et al. SNP array analysis of acute promyelocytic leukemia may be of prognostic relevance and identifies a potential high risk group with recurrent deletions on chromosomal subband 1q31.3 Genes Chromosomes Cancer 51 2012 756 767
27. W.W. Pang, J.V. Pluvinage, E.A. Price, K. Sridhar, D.A. Arber, P.L. Greenberg, S.L. Schrier, C.Y. Park, and I.L. Weissman Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes Proc. Natl. Acad. Sci. USA 110 2013 3011 3016
28. E. Papaemmanuil, M. Gerstung, L. Malcovati, S. Tauro, G. Gundem, P. Van Loo, C.J. Yoon, P. Ellis, D.C. Wedge, A. Pellagatti Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium Clinical and biological implications of driver mutations in myelodysplastic syndromes Blood 122 2013 3616 3627 quiz 3699
29. M.H. Raaijmakers Myelodysplastic syndromes: revisiting the role of the bone marrow microenvironment in disease pathogenesis Int. J. Hematol. 95 2012 17 25
30. M.H. Raaijmakers, S. Mukherjee, S. Guo, S. Zhang, T. Kobayashi, J.A. Schoonmaker, B.L. Ebert, F. Al-Shahrour, R.P. Hasserjian, and E.O. Scadden et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia Nature 464 2010 852 857
31. M. Rehn, A. Olsson, K. Reckzeh, E. Diffner, P. Carmeliet, G. Landberg, and J. Cammenga Hypoxic induction of vascular endothelial growth factor regulates murine hematopoietic stem cell function in the low-oxygenic niche Blood 118 2011 1534 1543
32. K. Schepers, E.M. Pietras, D. Reynaud, J. Flach, M. Binnewies, T. Garg, A.J. Wagers, E.C. Hsiao, and E. Passegué Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche Cell Stem Cell 13 2013 285 299
33. L.I. Shlush, S. Zandi, A. Mitchell, W.C. Chen, J.M. Brandwein, V. Gupta, J.A. Kennedy, A.D. Schimmer, A.C. Schuh, K.W. Yee HALT Pan-Leukemia Gene Panel Consortium Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia Nature 506 2014 328 333
34. I. Sloma, X. Jiang, A.C. Eaves, and C.J. Eaves Insights into the stem cells of chronic myeloid leukemia Leukemia 24 2010 1823 1833
35. A. Subramanian, P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, M.A. Gillette, A. Paulovich, S.L. Pomeroy, T.R. Golub, E.S. Lander, and J.P. Mesirov Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proc. Natl. Acad. Sci. USA 102 2005 15545 15550
36. R. Tehranchi, P.S. Woll, K. Anderson, N. Buza-Vidas, T. Mizukami, A.J. Mead, I. Astrand-Grundström, B. Strömbeck, A. Horvat, and H. Ferry et al. Persistent malignant stem cells in del(5q) myelodysplasia in remission N. Engl. J. Med. 363 2010 1025 1037
37. E. Thanopoulou, J. Cashman, T. Kakagianne, A. Eaves, N. Zoumbos, and C. Eaves Engraftment of NOD/SCID-beta2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome Blood 103 2004 4285 4293
38. T. Walenda, G. Bokermann, M.S. Ventura Ferreira, D.M. Piroth, T. Hieronymus, S. Neuss, M. Zenke, A.D. Ho, A.M. Müller, and W. Wagner Synergistic effects of growth factors and mesenchymal stromal cells for expansion of hematopoietic stem and progenitor cells Exp. Hematol. 39 2011 617 628
39. C.R. Walkley, G.H. Olsen, S. Dworkin, S.A. Fabb, J. Swann, G.A. McArthur, S.V. Westmoreland, P. Chambon, D.T. Scadden, and L.E. Purton A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency Cell 129 2007 1097 1110
40. M.J. Walter, D. Shen, L. Ding, J. Shao, D.C. Koboldt, K. Chen, D.E. Larson, M.D. McLellan, D. Dooling, and R. Abbott et al. Clonal architecture of secondary acute myeloid leukemia N. Engl. J. Med. 366 2012 1090 1098
41. N.J. White, E. Nacheva, F.A. Asimakopoulos, D. Bloxham, B. Paul, and A.R. Green Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells Blood 83 1994 2809 2816
42. M. Wunderlich, F.S. Chou, K.A. Link, B. Mizukawa, R.L. Perry, M. Carroll, and J.C. Mulloy AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3 Leukemia 24 2010 1785 1788
43. B. Zhang, M. Li, T. McDonald, T.L. Holyoake, R.T. Moon, D. Campana, L. Shultz, and R. Bhatia Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-β-catenin signaling Blood 121 2013 1824 1838
44. J. Zheng, M. Umikawa, C. Cui, J. Li, X. Chen, C. Zhang, H. Huynh, X. Kang, R. Silvany, and X. Wan et al. Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development Nature 485 2012 656 660